How Many Eye Injections Will You Need in Total?

An anti-VEGF injection is a tiny amount of medicine placed into the vitreous, the clear jelly that fills the back of your eye, after numbing drops. The medicine blocks vascular endothelial growth factor, a signal that drives leaky, fragile blood vessels to grow under the retina in wet AMD¹. Calming those vessels reduces swelling and bleeding so the retina can work better. The effect is real but temporary, which is the core reason the treatment repeats. As the drug wears off over weeks, the underlying tendency to leak can return, and another dose keeps it in check.

It helps to think of these injections the way you might think of blood pressure pills. Wet AMD is a chronic condition, and while injections may preserve and sometimes improve vision, they do not remove the underlying disease¹. Stopping simply because your vision feels fine can allow the problem to come back quietly, sometimes before you notice a change. This is why your doctor keeps checking your eye even during good stretches. The aim is not to reach zero injections as fast as possible, but to use the fewest injections that still keep the disease quiet.

Wet AMD is the most common reason for ongoing anti-VEGF injections, but it is not the only one. Anti-VEGF injections are also used for diabetic macular edema and swelling from retinal vein occlusions, conditions that likewise tend to need repeated treatment over time³. The general pattern is similar across these conditions: an early, more intensive phase to dry the retina, then a maintenance phase spaced out as far as the eye safely allows. Your total number depends heavily on which condition you have and how it behaves, so numbers from a friend with a different diagnosis may not match yours.

Most side effects are mild and settle on their own. Common effects around an anti-VEGF injection include a red spot on the white of the eye from a small surface bleed and brief eye discomfort, and a short-lived rise in eye pressure can occur within about an hour of the injection⁵. Many people also notice a few new floaters or a gritty feeling for a day. These are expected and usually need nothing more than time. Knowing they are normal can spare you a worried call, while still leaving room to recognize the less common problems that do need attention.

Rare but serious problems are the reason to know the warning signs. Injections into the eye have been linked to endophthalmitis, a serious infection inside the eye, and to retinal detachment, and any signs such as increasing pain, worsening redness, or dropping vision after an injection should be reported to your eye doctor without delay⁵. The reassuring part is that these events are uncommon, and caught early they are treatable. That balance, uncommon but urgent, is exactly why the advice is to call the same day rather than wait, and not to assume a change is just the usual soreness.

A fair worry is whether many injections stack up danger. Each injection carries a small, mostly one-time risk of infection, so more injections mean more chances for a rare event, but the per-injection risk stays low each time rather than growing. Because active intraocular inflammation and eye infection are reasons an injection is not given, your team screens for problems before each dose to keep repeated treatment as safe as possible⁵. For most people the well-established benefit of protecting vision outweighs the small risk of each injection, which is why long-term treatment is recommended despite the number.

Often the honest answer is that treatment is long-term, measured in years, though not always literally lifelong. Wet AMD is a chronic condition that is controlled rather than cured, so most people continue on some schedule for a long time. The good news is that the pace usually eases after the intensive early phase, and some eyes become quiet enough for widely spaced injections. Your doctor will keep looking for the longest safe gap, so think of it as an ongoing plan that is regularly adjusted, not an endless fixed burden.

Sometimes, but only your retina doctor can judge when. A small number of eyes become inactive enough that injections are paused and watched closely, and some scarred eyes stop benefiting and treatment is reconsidered. Stopping on your own, though, is risky, because wet AMD can flare quietly and vision lost to a flare is often hard to recover. If you are hoping to stop, raise it with your doctor rather than skipping visits. Together you can test longer intervals safely and see how your eye responds before deciding.

For many people, yes. The first year tends to be the busiest, with injections close together to dry the retina, and later years are often lighter. In one five-year follow-up, people averaged roughly four to five injections a year in years three through five, fewer than a strict monthly plan. That said, some eyes stay active and need frequent treatment throughout. Whether your pace eases depends on how your disease behaves, which is why regular monitoring matters: it is what lets your doctor safely stretch the time between doses.

No, that is a risky myth. Injections work by holding leaky vessels in check, and the effect fades over weeks, so a missed or long-delayed dose can let fluid and bleeding return. Vision lost during a gap is often much harder to regain than it would have been to protect. An occasional reschedule handled promptly is usually fine, but a pattern of missed visits is one of the more common reasons vision slips. If appointments are hard, tell your team so they can help rather than letting doses lapse.

It can, for some people. Newer longer-acting medicines are designed to hold the disease for longer between doses, so they may lower your yearly total while giving similar protection. Faricimab, for example, can be given up to every 16 weeks after the first four monthly doses in wet AMD. Not every eye can safely stretch that far, and switching is not always the right move if your current drug is working well. It is a good question to raise with your doctor, who can weigh your eye's activity against the appeal of fewer visits.

Only if both eyes have a condition that calls for them. Many people start with one affected eye and later develop disease in the other, since wet AMD often eventually involves both eyes. If that happens, each eye is treated on its own schedule based on its own activity, and the two do not have to match. Your doctor watches the unaffected eye at your visits so a new problem is caught early. Having one eye treated does not mean the other definitely will need it, but it does raise the odds enough to keep watching.